Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-322-8 | CAS number: 638-16-4
Toxicological information
Skin sensitisation
Currently viewing:
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- no data on reliability check with positive control; more than 2-3 animals were used for primary irritation screen
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The described guinea pig maximisation test according to OECD 406 was conducted in 1993 before the guidance for the LLNA (OECD429, first adopted in 2002) was available, and before the method was fully established and validated. And since the result of the guinea pig maximisation test is considered to be scientifically valid, the test was not repeated also taking into account exposure and animal welfare considerations.
Test material
- Reference substance name:
- 1,3,5-triazine-2,4,6(1H,3H,5H)-trithione, trisodium salt
- EC Number:
- 241-749-5
- EC Name:
- 1,3,5-triazine-2,4,6(1H,3H,5H)-trithione, trisodium salt
- Cas Number:
- 17766-26-6
- Molecular formula:
- C3N3S3.3Na
- IUPAC Name:
- 1,3,5-triazine-2,4,6(1H,3H,5H)-trithione, trisodium salt
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Crl:(HA)BR VAF/Plus
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age at study initiation: males 5-6 weeks, females 6-7 weeks
- Weight at study initiation: males 278-399 g, females 334-450 g
- Housing: individually in suspended, stainless-steel mesh cages
- Diet: Agway Prolab Guinea Pig Diet certified pellets, ad libitum
- Water: tap water, ad libitum
- Acclimation period: 5 days
- Animal supplier: Charles River Laboratories, Kingston, NY, USA
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-21
- Humidity (%): 50-58
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 10 Feb 1993 To: 26 Mar 1993
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- - intradermal induction: 0.1% in vehicle, 1.0% in 1:1 mixture (v/v) FCA/water
- epidermal induction: 75% in vehicle
- epidermal challenge: 75% in vehicle
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- - intradermal induction: 0.1% in vehicle, 1.0% in 1:1 mixture (v/v) FCA/water
- epidermal induction: 75% in vehicle
- epidermal challenge: 75% in vehicle
- No. of animals per dose:
- 20 test animals and 20 control animals
- Details on study design:
- RANGE FINDING TEST
A primary irritation screen was conducted to determine the concentrations for intradermal and epicutaneous induction as well as for challenge exposure.
Intradermal injection (4 animals): 0.1, 1.0, 3.0 and 5.0% test substance in water or 1:1 mixture (v/v) FCA/water
Four pairs of intradermal injections (0.1 mL each) were made on each side of the vertebral column of each of four guinea pigs assigned. Approximately 48 h after the intradermal injections, sites were evaluated. The highest concentration that did not produce ulceration or necrosis (0.1% test material in vehicle and 1.0% test material in 1:1 mixture (v/v) FCA/water) was utilized for the intradermal induction phase of the sensitisation study.
Topical application (4 animals): 9.5, 19, 38 and 75% in vehicle
Each of 4 guinea pigs received 0.5 mL of each of the four selected concentrations of the test substance by applying each test concentration to patches and securing them with an elastic wrap. Approximately 24 h after initiation of exposure, the wraps and patches were removed and residual test material wiped away. 24 hours after patch removal, the application sites were evaluated for signs of irritation using Draize scoring system.
The concentration that produced minimal irritation was used for the topical induction phase and the concentration that produced no irritation for the challenge exposure of the study.
No signs of irritation were evident for any of the test concentrations. Therefore, 75% was used for both the topical induction and for the challenge exposure.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous, respectively)
- Exposure period: single injection (intradermal) and 48 h (epicutaneous)
- Test groups:
Intradermal (3 pairs of injections):
Injection 1: 0.1 mL test substance in water
Injection 2: 0.1 mL 1:1 mixture FCA/water
Injection 3: 0.1 mL test substance in a 1:1 mixture (v/v) FCA/water
Epicutaneous: 0.3 mL test substance in water
- Control group:
Intradermal (3 pairs of injections):
Injection 1: 0.1 mL water
Injection 2: 0.1 mL 1:1 mixture FCA/water
Injection 3: 0.1 mL water in a 1:1 mixture (v/v) FCA/water
Epicutaneous: 0.3 mL water
- Site: shoulder region (intradermal and epicutaneous)
- Frequency of applications: every 7 days
- Duration: Days 0-7
- Exposure period (epicutaneous induction): 48 h
- Concentrations: intradermal: 0.1% in water, 1% in 1:1 mixture (v/v) FCA/water; epicutaneous: 75%
B. CHALLENGE EXPOSURE
- No. of exposures: 1 (challenge)
- Day of challenge: 21 (challenge)
- Exposure period: 24 h
- Test groups: test substance and water only
- Control groups: test substance and water only
- Site: left flank (test substance) and right flank (water)
- Concentration: 75%
- Evaluation (hr after challenge): 48 and 72 h - Positive control substance(s):
- no
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- induction: 0.1 and 1%; challenge: 75 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no dermal responses
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: induction: 0.1 and 1%; challenge: 75 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no dermal responses.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- induction: 0.1 and 1%; challenge: 75 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no dermal responses
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: induction: 0.1 and 1%; challenge: 75 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no dermal responses.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- induction: 0%; challenge: 75 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no dermal responses
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: induction: 0%; challenge: 75 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no dermal responses.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- induction: 0%; challenge: 75 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no dermal responses
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: induction: 0%; challenge: 75 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no dermal responses.
- Group:
- positive control
- Remarks on result:
- not measured/tested
Any other information on results incl. tables
The animals gained weight normally during the study.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this skin sensitisation study in the guinea pig TMT was not sensitising.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
